Ellevest Inc’s Protalix BioTherapeutics PLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,494
Closed -$12.3K 446
2024
Q2
$12.3K Buy
+10,494
New +$12.3K ﹤0.01% 404